Quoi de neuf en thérapeutique dermatologique ?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quoi de neuf en thérapeutique dermatologique ?

Published:2021-12 Issue:8 Volume:1 Page:8S41-8S52
ISSN:2667-0623
Container-title:Annales de Dermatologie et de Vénéréologie - FMC
language:fr
Short-container-title:Annales de Dermatologie et de Vénéréologie - FMC

Author:

Richard M.-A.

Publisher

Elsevier BV

Reference63 articles.

1. Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients;Nettis;Br J Dermatol,2021

2. Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study;Touhouche;J Eur Acad Dermatol Venereol,2021

3. ECZTRA 3 study investigators. Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial;Silverberg;Br J Dermatol,2021

4. Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis;Yates;Arthritis Rheumatol,2021

5. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial;Blauvelt;JAMA Dermatol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3